Key result
DCB matches DES for 6-month restenosis, while lower post-PCI QFR predicts recurrence.
Why the study?
The optimal management of coronary in-stent restenosis remains challenging, and physiologic indices such as quantitative flow ratio may improve risk stratification and guide treatment beyond angiography alone.
Does post-procedural quantitative flow ratio (QFR) predict 6-month binary angiographic restenosis and major adverse cardiac events in patients undergoing PCI with drug-coated balloon or drug-eluting stent for coronary in-stent restenosis?
RCT (n=43)
Open-label
1:1 ratio using a dedicated web-based randomization system (post-hoc sub-study of OPEN-ISR)
No
Does post-procedural quantitative flow ratio (QFR) predict 6-month binary angiographic restenosis and major adverse cardiac events in patients undergoing PCI with drug-coated balloon or drug-eluting stent for coronary in-stent restenosis?
Post-procedural quantitative flow ratio (QFR) provides modest prognostic discrimination for 6-month binary angiographic restenosis after PCI for drug-eluting stent in-stent restenosis, with values below 0.91 identifying lesions at higher risk of recurrence.
Answers are grounded in this paper and cite their sources.
DCB and DES remain interchangeable for ISR; extends QFR as a modest post-procedural predictor of restenosis.
Background The optimal management of coronary in-stent restenosis (ISR) remains challenging. Physiologic indices such as quantitative flow ratio (QFR) may improve risk stratification and guide treatment beyond angiography alone. In the present study the diagnostic and prognostic value of QFR in patients with coronary ISR undergoing percutaneous coronary intervention (PCI) with a drug-coated balloon (DCB) or drug-eluting stent (DES) was evaluated. Methods We conducted a sub study of the prospective OPEN-ISR trial, including 43 patients (43 lesions) with angiographically documented ISR treated between November 2021 and September 2024. QFR was measured before and immediately after the intervention as well as at 6 months follow-up. The primary endpoints were binary angiographic restenosis and major adverse cardiac events at 6 months. Results A total of 43 patients with 43 ISR lesions were included. Post-procedural QFR was 0.94 ± 0.04. At a follow-up of 6 months, binary restenosis occurred in 35% of lesions. Patients with restenosis had significantly lower post-procedural QFR compared to those without (0.91 ± 0.05 vs. 0.95 ± 0.03 respectively; p = 0.05). The rate of reintervention in lesions treated with DES was comparable to those treated with DCB (44% vs. 30% respectively; p = 0.51). A post-procedural QFR threshold of 0.91 discriminated lesions with significantly higher risk of recurrence. Conclusions Physiologic assessment after PCI for coronary ISR provides important prognostic information. Suboptimal post-procedural QFR identifies lesions at increased risk of adverse outcomes and may help optimize ISR treatment strategies.
No takes yet. Share an insight, caveat, or question.
Jankó et al. (2026) conducted an RCT in Coronary drug-eluting stent in-stent restenosis (DES-ISR) (n=43). Drug-coated balloon (DCB) angioplasty and post-procedural Quantitative Flow Ratio (QFR) assessment vs. Drug-eluting stent (DES) implantation was evaluated on Binary angiographic restenosis (≥50% diameter stenosis) at 6 months (p=0.51). Drug-coated balloon angioplasty and drug-eluting stenting yielded comparable 6-month binary restenosis, while lower post-PCI QFR predicted restenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: